The challenges we face
Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.
How can the Innovation Nexus help me?
Speak directly to a GM AHSN advisor with NHS expertise
Help with navigating NHS procurement
Information about funding and investment
Help with setting up a trial of your innovation
Information on science parks and office locations
Connect you with relevant organisations
Event: Joint EFGCP-MedTech Europe conference, London, June 2015
Event: An Interactive Multi-Stakeholder Conference and Workshop of the Joint EFGCP-MedTech Europe Medical Technology Working Party on Ethics, Quality and Oversight in the Clinical Development of Medical Devices
Date: 15 & 16 June 2015
Location: University College London, London, United Kingdom
Clinical development of medical devices is a continual process spanning the full product lifecycle. Designing, executing, and ensuring oversight of clinical studies across this lifecycle, while meeting the highest standards of quality and ethics, is a special challenge for medical devices as it is for medicines.
The ongoing revision of the EU regulatory framework for medical devices seeks to establish new clinical evidence standards, aligning the rules - where useful and applicable to medical technology - with the new Clinical Trials Regulation for Medicinal Products. Greater harmonisation is also expected in terms of how Member States enforce these rules, such as through inspections and ethics committee overview.
This Joint EFGCP-MedTech Europe conference will explore existing best practices and forthcoming changes in the clinical development of medical devices. Through dialogue between regulators, patients, healthcare professionals, CROs and industry, the event will provide early insight into the future clinical evidence rules for medical devices, while offering regulators insight into the practical challenges facing their stakeholders.